Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Careful Connections: Building Association and Trust - 2Culinary Joys: Investigating Connoisseur Cooking at Home
- 3A Pompeii site reveals the recipe for Roman concrete. It contradicts a famous architect’s writings
- 4Pick Your Number one sort of blossom
- 5Monetary Security: Building Serious areas of strength for an Establishment
- A definitive Manual for 2024's Most In vogue Wedding Dresses
- Home Plan Tips for Seniors
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- Novo Nordisk gears up for December Ozempic launch in India, sources say
- Family Matters: Tips and Guidance for Effective Nurturing and Everyday Life
- UNICEF: More than 100 children killed in Gaza since ceasefire
- Invigorating Spots To Go Kayaking All over The Planet
- Israeli strikes in Gaza kill 25 people, Hamas health authority says
- What to watch for in weight loss drugs in 2026
